© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Name: Equilin
Chemical Formula: C18H20O2
Description: Equilin stands out as one of the natural estrogens found especially in urine from pregnant mares, a key ingredient often used in hormone replacement therapy. It appears as a pale yellow, crystalline powder with a somewhat distinct earthy, medicinal scent. Someone handling this powder outside a controlled lab notices a resilience to moisture in the air. Finding this compound present in pharmaceutical labs helps remind professionals of the continued significance of naturally derived hormones even in a synthetic age.
Main Hazards: Skin and eye irritation, respiratory tract irritation, possible reproductive toxicity, potential carcinogenic effect
Exposure Routes: Inhalation, skin absorption, accidental ingestion
Signal Word: Warning
Symbols: Exclamation mark, Health hazard
Summary: Lab workers know a tiny amount of powder escaping into the air sticks to the skin, gets inhaled without proper gear, and can raise real health risks over time, especially because of its hormonal activity. Skin rashes and chronic coughs happen way too often for anyone’s peace of mind, and documented studies tie repeated handling to shifts in hormone levels.
Main Substance: Equilin (>95%)
Synonyms: 3-Hydroxyestra-1,3,5(10),7-tetraen-17-one
Impurities: Trace related estrogens, solvent residue possible from synthesis or extraction
CAS Number: 474-86-2
Physical State: Solid, crystalline
Uses: Core use in pharmaceutical hormone therapy; some niche veterinary applications
Eye Contact: Rinse with gentle stream of water for at least fifteen minutes, making sure eyelids pull apart, then seek medical help if redness or pain lingers.
Skin Contact: Wash exposed area with mild soap and cool running water for several minutes; discard contaminated clothing. Years of lab work show that waiting too long to wash increases chance of dermatitis significantly.
Inhalation: Remove person from exposure and relocate to fresh air; provide oxygen support if breathing feels strained; medical assistance is crucial for heavy exposure.
Ingestion: Rinse mouth, try to induce vomiting only if approved by a medical professional; hospitalization is essential with accidental swallowing, as even small doses have been documented to disrupt body systems.
Flammability: Low, but smoke from burning equilin can cause toxic fumes.
Suitable Extinguishing Media: Use dry chemical, carbon dioxide, or water spray. Never rely on a simple water jet.
Protective Equipment Required: Full body gear with respiratory protection, since combustion byproducts may include phenolic and estrogenic toxins.
Special Advice: Firefighters remember how quickly powdery substances can aerosolize in heat, making smoke inhalation a far bigger threat than flames.
Precautions: Keep personnel clear of the area, ventilate space, and use protective gloves, goggles, and face mask.
Containment: Wet down powder to avoid dust formation, sweep carefully, collect in sealable containers.
Disposal: Follow chemical waste protocols for hazardous organics, never pour down drains.
Decontamination: Wash surfaces with alcohol solution or suitable solvent; stories around the lab underscore how dry sweeping leaves behind unseen traces easily picked up days later.
Precautions for Handling: Always use gloves and work under fume hood; avoid generating dust and never eat or drink near work area. For people in pharmacy prep labs, even short cuts like setting down samples outside the hood end up leading to contamination.
Storage Conditions: Store in tightly sealed amber-glass bottles at 2–8°C, away from heat and light. Keep separate from incompatible oxidizers.
Shelf Life: Degrades with exposure to humidity and UV; always check for clumping or color change before use.
Engineering Controls: Use local exhaust ventilation in all compounding areas; glove boxes if feasible for powder weighing.
Personal Protection: Gloves (nitrile or neoprene), chemical safety goggles, lab coat, and certified respirator for dust exposure above limits. Colleagues who forgo respirators often end up reporting headaches or hormone effects.
Exposure Limits: No evidence for established occupational limits, but good practice calls for ALARA (“as low as reasonably achievable”) principles with all pharmaceutical hormones.
Hygiene: Thorough hand washing and laundering of reusable protective clothing limits risk of accidental spread outside the lab.
Appearance: Pale yellow crystalline powder
Odor: Slightly earthy, faintly medicinal
Melting Point: 251–253°C
Boiling Point: Decomposes before boiling
Solubility: Soluble in organic solvents; almost insoluble in water
Molecular Weight: 268.35 g/mol
Vapor Pressure: Negligible
pH: Not applicable for solids
Density: Approximately 1.17 g/cm3
Chemical Stability: Stable under dry, cool, protected conditions; unstable in presence of acids, bases, or oxidizers.
Reactivity: Susceptible to oxidation by strong agents, quickly degrades in basic or acidic media.
Incompatibilities: Avoid strong oxidizers, acids, alkalis. Case histories show big trouble from mixing hormone drugs with bleach or peroxide-based cleaners.
Decomposition Products: Toxic fumes, including carbon monoxide, carbon dioxide, unknown estrogen derivatives.
Routes of Exposure: Skin, eyes, respiratory, ingestion
Acute Effects: Irritation, nausea, dizziness, allergic responses
Chronic Effects: Hormonal imbalance, increased risk of cancer (especially reproductive organs), reproductive toxicity
Sensitization: Some people become allergy-prone after repeated exposure, based on occupational studies of health techs working with estrogenic compounds.
Evidence: Many animal studies, some human epidemiological data, support links between estrogenic drug exposure and altered reproductive or developmental outcomes.
Environmental Fate: Persistent in soil and surface waters, does not degrade rapidly.
Toxicity to Aquatic Life: Disrupts endocrine systems in fish and amphibians at minor concentrations, with studies showing population-level harm in areas near pharmaceutical waste sites.
Bioaccumulation: Builds up across food chains, evidence shows long-term hormonal disruption in downstream wildlife.
Mobility: Low water solubility reduces spread in aquifers, but strong binding to organic material means soil contamination is tough to reverse.
Waste Treatment: Incineration at approved chemical facilities; dilution or landfill not recommended due to risk of leaching and ecosystem impact.
Container Cleanup: Triple rinsing with organic solvent, then treat residue as hazardous waste.
Legal Restrictions: Local laws often require strict documentation and tracking of hormone waste, reflecting the real-world consequences careless disposal has had on community water supplies and wildlife health.
UN Classification: Not regulated under most road, air, or sea shipping codes, although handling rules apply due to pharmaceutical use.
Advice for Shipping: Use sealed, labeled secondary containment, minimize physical shock, and avoid temperature extremes.
Incidents: Occasional transport spills in the past led to required cleanups, as even microgram releases can contaminate cargo areas or lead to regulatory fines.
Global Pharmacopeia Status: Recognized in several pharmacopoeias, prescription-only use.
Workplace Controls: OSHA and NIOSH recommend restrictive access; many countries apply their own strict workplace estrogen standards.
Environmental Regulations: National and regional bodies demand reporting and strict management of estrogen waste streams. Inspections ramp up wherever history shows past waste management issues, and more frequent audits reflect public health lessons written in river toxicity data.
Future Considerations: Growing evidence on ecosystem impact continues pushing regulators toward stricter collection, treatment, and monitoring for estrogenic compounds like equilin in both human and animal medical markets.
